Delivery Order SPE2DB22D2006-SPE2DB25FW4JW
Award Date 9/26/25
Potential Completion Date 10/20/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $93,868.32 by the Defense Logistics Agency's Medical Supply Chain for the supply of Xeomin 200 Unit Vials. The contract, awarded on August 7, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 28, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Xeomin 100 Unit Vials with a ceiling value of $35,535.50 under a firm fixed-price contract. This non-set-aside award is scheduled for completion by October 8, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a competitively awarded procurement action sourced through the company's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,644.72 by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Xeomin 200 unit vials. The contract utilizes firm fixed price terms with an ultimate completion date of June 24, 2025, and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to meet federal procurement...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on August 23, 2025, for the supply of Xeomin 100 Unit vials. The contract ceiling value is $11,174.80, with an ultimate completion date of September 12, 2025. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside contract awarded through competitive procurement, consistent with AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $59,699.64 by the Defense Logistics Agency (DLA) on August 6, 2025. The contract, utilizing firm fixed-price pricing, covers the supply of Xeomin 100 unit vials and is scheduled for completion by August 27, 2025. The award was made through open competition with no set-aside designation, with performance taking place at the vendor's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 14, 2025, for the supply of Xeomin 200 Unit Vials valued at $93,868.32, with completion scheduled for August 4, 2025. This competitively awarded, firm fixed-price delivery order was issued by the Medical Supply Chain division of the Defense Logistics Agency and carries no set-aside designation. The contract reflects the Defense Department's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,057.32 by the Defense Logistics Agency on June 2, 2025, for the supply of Xeomin 100 unit vials, with completion scheduled for June 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $70,401.24 on September 17, 2025, for the supply of Xeomin 200 Unit Vials. This firm fixed-price contract, with an ultimate completion date of October 8, 2025, was awarded without a set-aside designation through competitive procurement. The award is funded by the Defense Logistics Agency's Medical Supply Chain, reflecting the Department of...
- The Defense Logistics Agency awarded a delivery order valued at $13,409.76 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials, with a completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 13, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order falls under the company's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $20,114.64 for 100-unit vials of Xeomin on September 18, 2025, with completion scheduled for October 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded procurement supporting federal medical supply requirements. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken,...